Evaluating the role of biological age in osteoporosis risk among middle-aged and older adults: A nationwide perspective

IF 3.5 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Bone Pub Date : 2024-09-14 DOI:10.1016/j.bone.2024.117255
Guomao Zhu , Buyu Guo , Jinqian Liang
{"title":"Evaluating the role of biological age in osteoporosis risk among middle-aged and older adults: A nationwide perspective","authors":"Guomao Zhu ,&nbsp;Buyu Guo ,&nbsp;Jinqian Liang","doi":"10.1016/j.bone.2024.117255","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>This study aimed to investigate the association between biological age acceleration and osteoporosis (OP) risk in middle-aged and older adults using data from the National Health and Nutrition Examination Survey (NHANES). The research focused on analyzing the relationship between two biological aging metrics, Klemera-Doubal Method Age (KDMAge) and Phenotypic Age (PhenoAge), and OP risk.</p></div><div><h3>Methods</h3><p>The study analyzed data from NHANES, which included 6550 participants aged 50 and above from survey cycles 2005–2010 and 2017–2018. Linear and logistic regression were used to investigate the relationship between biological age acceleration (KDMAgeAccel and PhenoAgeAccel) and OP. Subgroup analysis was performed by age, gender and other factors. Multivariable Cox regression analysis yielded Hazard Ratios (HRs) relating biological age acceleration to mortality were evaluated. The study also considered the mediating roles of body mass index (BMI).</p></div><div><h3>Results</h3><p>KDMAgeAccel (odds ratio [OR] = 2.34, 95 % CI, 1.72–3.18) and PhenoAgeAccel (OR = 2.03, 95 % CI, 1.48–2.78) were significantly associated with increased OP risk and reduced bone mineral density (BMD). Specifically, higher KDMAgeAccel and PhenoAgeAccel were linked to higher OP prevalence and lower BMD at multiple sites. Subgroup analyses indicated that the association between accelerated biological age acceleration and OP risk was consistent across different demographics. Mediation analysis revealed that BMI partially mediated the relationship between accelerated biological age and OP, although other mechanisms are likely involved. Statistical analysis indicated that individuals with higher biological age metrics had increased mortality risk related to OP.</p></div><div><h3>Conclusion</h3><p>The findings suggest that accelerated biological age is a robust predictor of OP risk and related mortality. KDMAgeAccel and PhenoAgeAccel could serve as valuable biomarkers for identifying individuals at high risk for OP, guiding preventive strategies.</p></div>","PeriodicalId":9301,"journal":{"name":"Bone","volume":"189 ","pages":"Article 117255"},"PeriodicalIF":3.5000,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bone","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S8756328224002448","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

This study aimed to investigate the association between biological age acceleration and osteoporosis (OP) risk in middle-aged and older adults using data from the National Health and Nutrition Examination Survey (NHANES). The research focused on analyzing the relationship between two biological aging metrics, Klemera-Doubal Method Age (KDMAge) and Phenotypic Age (PhenoAge), and OP risk.

Methods

The study analyzed data from NHANES, which included 6550 participants aged 50 and above from survey cycles 2005–2010 and 2017–2018. Linear and logistic regression were used to investigate the relationship between biological age acceleration (KDMAgeAccel and PhenoAgeAccel) and OP. Subgroup analysis was performed by age, gender and other factors. Multivariable Cox regression analysis yielded Hazard Ratios (HRs) relating biological age acceleration to mortality were evaluated. The study also considered the mediating roles of body mass index (BMI).

Results

KDMAgeAccel (odds ratio [OR] = 2.34, 95 % CI, 1.72–3.18) and PhenoAgeAccel (OR = 2.03, 95 % CI, 1.48–2.78) were significantly associated with increased OP risk and reduced bone mineral density (BMD). Specifically, higher KDMAgeAccel and PhenoAgeAccel were linked to higher OP prevalence and lower BMD at multiple sites. Subgroup analyses indicated that the association between accelerated biological age acceleration and OP risk was consistent across different demographics. Mediation analysis revealed that BMI partially mediated the relationship between accelerated biological age and OP, although other mechanisms are likely involved. Statistical analysis indicated that individuals with higher biological age metrics had increased mortality risk related to OP.

Conclusion

The findings suggest that accelerated biological age is a robust predictor of OP risk and related mortality. KDMAgeAccel and PhenoAgeAccel could serve as valuable biomarkers for identifying individuals at high risk for OP, guiding preventive strategies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
评估生理年龄在中老年人骨质疏松症风险中的作用:全国视角
目的本研究旨在利用美国国家健康与营养调查(NHANES)的数据,调查中老年人的生物年龄加速度与骨质疏松症(OP)风险之间的关系。研究重点分析了克莱默拉-杜巴法年龄(KDMAge)和表型年龄(Phenotypic Age,PhenoAge)这两个生物衰老指标与OP风险之间的关系。研究分析了NHANES的数据,其中包括2005-2010年和2017-2018年调查周期中6550名50岁及以上的参与者。研究采用线性回归和逻辑回归来探讨生物年龄加速度(KDMAgeAccel 和 PhenoAgeAccel)与 OP 之间的关系。根据年龄、性别和其他因素进行了分组分析。通过多变量考克斯回归分析,评估了生物年龄加速与死亡率之间的危险比(HRs)。研究还考虑了体重指数(BMI)的中介作用。结果KDMAgeAccel(比值比 [OR] = 2.34,95 % CI,1.72-3.18)和 PhenoAgeAccel(比值比 = 2.03,95 % CI,1.48-2.78)与 OP 风险增加和骨矿密度(BMD)降低显著相关。具体来说,较高的 KDMAgeAccel 和 PhenoAgeAccel 与 OP 患病率较高和多个部位的 BMD 较低有关。亚组分析表明,生物年龄加速与 OP 风险之间的关系在不同人口统计学中是一致的。中介分析显示,体重指数(BMI)在一定程度上中介了生物年龄加速与 OP 之间的关系,但也可能涉及其他机制。统计分析表明,生物年龄指标较高的个体与 OP 相关的死亡风险增加。KDMAgeAccel和PhenoAgeAccel可作为识别OP高风险人群的重要生物标记物,为预防策略提供指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Bone
Bone 医学-内分泌学与代谢
CiteScore
8.90
自引率
4.90%
发文量
264
审稿时长
30 days
期刊介绍: BONE is an interdisciplinary forum for the rapid publication of original articles and reviews on basic, translational, and clinical aspects of bone and mineral metabolism. The Journal also encourages submissions related to interactions of bone with other organ systems, including cartilage, endocrine, muscle, fat, neural, vascular, gastrointestinal, hematopoietic, and immune systems. Particular attention is placed on the application of experimental studies to clinical practice.
期刊最新文献
Immune microenvironment of cancer bone metastasis Calorie restriction induces mandible bone loss by regulating mitochondrial function Innate immune response to bone fracture healing Tertiary hyperparathyroidism in two paediatric patients with X-linked hypophosphatemia during Burosumab treatment Exposure to fluoride and risk of primary bone cancer: A systematic review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1